Dr. Jeremy M. Kilburn
Claim this profileGibbs Cancer Center-Pelham
Studies Lung Cancer
Studies Cancer
8 reported clinical trials
21 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage IV
Stage I
2Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Jeremy M. Kilburn is currently running
Surgery and Radiation vs. Radiation Alone
for Brain Cancer
This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation to target tumors and minimizes effect on normal surrounding brain tissue. The combination of surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases. This study investigates whether treating with SRS before surgery may be better than SRS after surgery in reducing the possibility of the tumor coming back, reducing or preventing the cancer from spreading to other areas of the brain and reducing the risk of scarring on the brain from radiation.
Recruiting2 awards Phase 3
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
More about Jeremy M. Kilburn
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jeremy M. Kilburn has experience with
- Stereotactic Body Radiation Therapy
- Stereotactic Radiosurgery
- Atezolizumab
- Quality-of-Life Assessment
- Biospecimen Collection
- Questionnaire Administration
Breakdown of trials Jeremy M. Kilburn has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy M. Kilburn specialize in?
Jeremy M. Kilburn focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage IV.
Is Jeremy M. Kilburn currently recruiting for clinical trials?
Yes, Jeremy M. Kilburn is currently recruiting for 5 clinical trials in Greer South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jeremy M. Kilburn has studied deeply?
Yes, Jeremy M. Kilburn has studied treatments such as Stereotactic Body Radiation Therapy, Stereotactic Radiosurgery, Atezolizumab.
What is the best way to schedule an appointment with Jeremy M. Kilburn?
Apply for one of the trials that Jeremy M. Kilburn is conducting.
What is the office address of Jeremy M. Kilburn?
The office of Jeremy M. Kilburn is located at: Gibbs Cancer Center-Pelham, Greer, South Carolina 29651 United States. This is the address for their practice at the Gibbs Cancer Center-Pelham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.